Our Team
Minmin Yang, PhD
Founder, Chairman, Chief Executive Officer
• 20+ years experience in chemistry and drug R&D
• PhD/Postdoctoral at Auburn University
• Served at Roche Palo Alto and Roche China, with increasing responsibilities from group leader to section head of medicinal chemistry
• 80 articles and patents, including 16 international patents
Shuhai Zhao, PhD
Co-founder, Chief Scientific Officer
• 25+ years experience in chemistry and drug R&D
• PhD at University of Paris-Sud
• Postdoctoral at Massachusetts Institute of Technology
• Served at Hoechst-Celanese, Roche US/China R&D Center
• Led 5 project teams and discovered 7 clinical candidates, 3 of which have entered clinical trials and 2 were advanced into phase II. Contributed to the invention of FanaptTM
• 70 articles and patents, including 25 international patents
David Chen, PhD
Chief Operating Officer, Head of CDMO
• 30+ years experience in analytical R&D, quality management & operation
• PhD at University of Miami
• Served as President at Jiuzhou Pharma; VP of Quality at Jiuzhou & Desano; Director of Quality at Roche China
• Hosted >50 regulatory inspections from NMPA, FDA, EDQM, WHO, and etc.
Shijie Zhang, PhD
Chief Technology Officer
• 25+ years experience in process R&D, manufacturing & CMC strategy
• PhD at Emory University
• Served as Director of Process Chemistry and API Production at Agios, USA
• Successfully advanced 2 compounds from preclinical to commercial, 2 to Phase III, 1 to Phase II
• 40+ articles and patents
Dezhi Sha, PhD
Sr. VP of Process Technology & Manufacturing
• 30+ years experience in process R&D, manufacturing & operations
• PhD at University of Mississippi
• Served as VP of Process Technology, Site GM at Irix & Patheon
• Managed hundreds of challenging API projects, advanced a dozen new APIs from toxicity batch to commercial launch
• Oversaw numerous FDA inspections, including PAIs, many times achieving outcomes with no Form 483s
Jing Li, PhD
Sr. VP of Process Chemistry, President of PharmaBlock (USA), Inc.
• 20+ years experience in new drug research and development and process development
• PhD at Nanjing University
• Postdoctoral at Southwestern Medical Center, Dallas, USA
• Served as Associate Director at Merck US, focusing on route scouting & optimization, and managed process chemistry outsourcing projects
• 40 articles and patents, including 18 international patents
Minmin Yang, PhD
Founder, Chairman, Chief Executive Officer
• 20+ years experience in chemistry and drug R&D
• PhD/Postdoctoral at Auburn University
• Served at Roche Palo Alto and Roche China, with increasing responsibilities from group leader to section head of medicinal chemistry
• 80 articles and patents, including 16 international patents
Shuhai Zhao, PhD
Co-founder, Chief Scientific Officer
• 25+ years experience in chemistry and drug R&D
• PhD at University of Paris-Sud
• Postdoctoral at Massachusetts Institute of Technology
• Served at Hoechst-Celanese, Roche US/China R&D Center
• Led 5 project teams and discovered 7 clinical candidates, 3 of which have entered clinical trials and 2 were advanced into phase II. Contributed to the invention of FanaptTM
• 70 articles and patents, including 25 international patents
David Chen, PhD
Chief Operating Officer, Head of CDMO
• 30+ years experience in analytical R&D, quality management & operation
• PhD at University of Miami
• Served as President at Jiuzhou Pharma; VP of Quality at Jiuzhou & Desano; Director of Quality at Roche China
• Hosted >50 regulatory inspections from NMPA, FDA, EDQM, WHO, and etc.
Shijie Zhang, PhD
Chief Technology Officer
• 25+ years experience in process R&D, manufacturing & CMC strategy
• PhD at Emory University
• Served as Director of Process Chemistry and API Production at Agios, USA
• Successfully advanced 2 compounds from preclinical to commercial, 2 to Phase III, 1 to Phase II
• 40+ articles and patents
Dezhi Sha, PhD
Sr. VP of Process Technology & Manufacturing
• 30+ years experience in process R&D, manufacturing & operations
• PhD at University of Mississippi
• Served as VP of Process Technology, Site GM at Irix & Patheon
• Managed hundreds of challenging API projects, advanced a dozen new APIs from toxicity batch to commercial launch
• Oversaw numerous FDA inspections, including PAIs, many times achieving outcomes with no Form 483s
Jing Li, PhD
Sr. VP of Process Chemistry, President of PharmaBlock (USA), Inc.
• 20+ years experience in new drug research and development and process development
• PhD at Nanjing University
• Postdoctoral at Southwestern Medical Center, Dallas, USA
• Served as Associate Director at Merck US, focusing on route scouting & optimization, and managed process chemistry outsourcing projects
• 40 articles and patents, including 18 international patents
